BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15493559)

  • 21. Predictors of final histology in patients with endometrial cancer.
    Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
    Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of surgical cytoreduction in Stage IV endometrial carcinoma.
    Chi DS; Welshinger M; Venkatraman ES; Barakat RR
    Gynecol Oncol; 1997 Oct; 67(1):56-60. PubMed ID: 9345357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome of pathologic Stage IIA endometrial adenocarcinoma after intravaginal brachytherapy alone.
    Siddiqui F; Ibrahim DR; Aref I; Lu M; Kim WS; Schultz D; Elshaikh MA
    Brachytherapy; 2009; 8(4):396-400. PubMed ID: 19733127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of lower uterine segment involvement in surgically staged endometrial cancer patients with negative nodes.
    Brown AK; Madom L; Moore R; Granai CO; DiSilvestro P
    Gynecol Oncol; 2007 Apr; 105(1):55-8. PubMed ID: 17157904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of the degree of myometrial invasion in patients with stage IB endometrial cancer.
    Gemer O; Uriev L; Harkovsky T; Peled R; Ben-Dor D; Barak F; Segal S
    Eur J Gynaecol Oncol; 2004; 25(3):336-8. PubMed ID: 15171313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women.
    Macdonald OK; Sause WT; Lee RJ; Lee CM; Dodson MK; Zempolich K; Gaffney DK
    Gynecol Oncol; 2006 Nov; 103(2):661-6. PubMed ID: 16797682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
    Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR
    Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
    Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
    Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
    Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
    Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival.
    Lambrou NC; Gómez-Marín O; Mirhashemi R; Beach H; Salom E; Almeida-Parra Z; Peñalver M
    Gynecol Oncol; 2004 Jun; 93(3):653-8. PubMed ID: 15196860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age as a prognostic factor for recurrence in patients with endometrial carcinoma.
    Mundt AJ; Waggoner S; Yamada D; Rotmensch J; Connell PP
    Gynecol Oncol; 2000 Oct; 79(1):79-85. PubMed ID: 11006036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The outcome of patients with stage I endometrial cancer involving the lower uterine segment.
    Lavie O; Uriev L; Gdalevich M; Barak F; Peer G; Auslender R; Anteby E; Gemer O
    Int J Gynecol Cancer; 2008; 18(5):1079-83. PubMed ID: 18081795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and pathologic correlates in surgical stage II endometrial carcinoma.
    Cohn DE; Woeste EM; Cacchio S; Zanagnolo VL; Havrilesky LJ; Mariani A; Podratz KC; Huh WK; Whitworth JM; McMeekin DS; Powell MA; Boyd E; Phillips GS; Fowler JM
    Obstet Gynecol; 2007 May; 109(5):1062-7. PubMed ID: 17470583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor.
    Jobsen JJ; ten Cate LN; Lybeert ML; van der Steen-Banasik EM; Scholten A; van der Palen J; Slot A; Kroese MC; Schutter EM; Siesling S
    Gynecol Oncol; 2010 Apr; 117(1):32-6. PubMed ID: 20060158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer.
    Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ
    Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
    Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
    Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study.
    Gemer O; Arie AB; Levy T; Gdalevich M; Lorian M; Barak F; Anteby E; Lavie O
    Eur J Surg Oncol; 2007 Jun; 33(5):644-7. PubMed ID: 17317084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.